These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
33. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia. Polski A; Sibug Saber M; Kim JW; Berry JL Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057 [TBL] [Abstract][Full Text] [Related]
37. Immunoreduction of ocular surface tumours with intralesional interferon alpha-2a. Kim SE; Salvi SM Eye (Lond); 2018 Feb; 32(2):460-462. PubMed ID: 28937145 [TBL] [Abstract][Full Text] [Related]
38. Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia. Nuruddin M; Roy SR; Hoque F Oman J Ophthalmol; 2022; 15(1):81-84. PubMed ID: 35388258 [TBL] [Abstract][Full Text] [Related]
39. Topical medical therapies for ocular surface tumors. Poothullil AM; Colby KA Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014 [TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Schechter BA; Koreishi AF; Karp CL; Feuer W Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]